【ChiCTR2400091460】A group-based compassionate mind training on depression in Hong Kong: a pilot randomized control trial
ChiCTR2400091460
尚未开始
/
/
/
2024-10-29
/
/
/
A group-based compassionate mind training on depression in Hong Kong: a pilot randomized control trial
A group-based compassionate mind training on depression in Hong Kong: a pilot randomized control trial
The study is to evaluate the effectiveness of the group-based compassionate mind training (CMT) protocol on patients' psychopathology conditions, fears of compassion and self-compassion. The study would also consider participants' homework compliance in the evaluation of treatment outcomes.
随机平行对照
其它
Participants will be allocated to the intervention group or control group (1:1 ratio) randomly. A research assistant who is not involved in the intervention would generate the random numbers by computer.
/
Self-finance
/
64
/
2024-10-30
2025-12-31
/
Inclusion criteria: 1) aged 18 or above, 2) patients from psychiatric and/or clinical psychology outpatient clinics who are experiencing depressive disorders, particularly major depressive disorder, persistent depressive disorder, and other specified depressive disorder (operationalized as fulfilling the criteria in Diagnostic and Statistical Manual of Mental Disorders: Fifth edition, text revision (DSM-V-TR)). Clinical psychologists would further verify the diagnosis with reference to the DSM-V-TR criteria. 3) Meanwhile, recruited participants’ concurrent psychotrophic medications were said to be stable during the study.；
请登录查看Patients with neurodevelopmental disorders, schizophrenia spectrum and other psychotic disorders, bipolar disorders, obsessive-compulsive disorders, comorbid substance use disorder, personality disorders, potential risks to self and/or others, neurocognitive disorders, intellectual disabilities, physical disabilities, severe medical illnesses (such as newly diagnosis at acute phase, potential to undergo intensive treatment), who could not read Chinese and speak in Cantonese, who did not read and write, as well as those who had previously received compassion-based or mindfulness-based interventions.；
请登录查看Department of Psychology, The Chinese University of Hong Kong
/
Department of Psychology, The Chinese University of Hong Kong的其他临床试验
Hospital Authority Hong Kong SAR的其他临床试验
最新临床资讯
-
飞眸医疗首例人体临床试验（FIH）成功开展，国产飞秒屈光设备竞逐540亿屈光市场
动脉网-最新2026-09-10
-
和铂医药：超长效靶向TSLP抗体哮喘二期临床取得阳性结果，三期临床已启动
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
动脉网-最新2026-09-09
-
药明康德2026-09-09
-
一度医药2026-09-08
-
阿斯利康中国2026-09-08
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 20 8
-
摩熵咨询 20 11
-
摩熵咨询 34 56
-
颁布机构：国家药品监督管理局 2026-09-10
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31